Kunal C Kadakia1, Shaina A Rozell1, Anish A Butala2, Charles L Loprinzi3. 1. Division of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. 2. Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. 3. Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: cloprinzi@mayo.edu.
Abstract
CONTEXT: Conventional chemotherapy leads to multiple adverse mucocutaneous complications such as oral mucositis, alopecia, ocular toxicity, and onycholysis. Limited pharmacologic interventions are available for preventing these clinical problems. OBJECTIVES: This study aimed to critically review the role of cryotherapy (regional hypothermia) for alleviating these adverse symptoms. METHODS: A narrative review was performed, with an emphasis on randomized controlled trials. A comprehensive search using PubMed, Ovid, Embase, and MEDLINE(®) was completed. References of all cited articles also were reviewed. Data from the review were composed of articles published between 1970 and May 2013. RESULTS: Available evidence suggests that regional hypothermia decreases the burden of chemotherapy-related oral mucositis, alopecia, ocular toxicity, and onycholysis. The major limitations of studies include the absence of blinded control groups and variable clinical end points. CONCLUSION: Regional hypothermia decreases the burden of these four chemotherapy-induced complications and is well tolerated. More research is needed to determine what subgroups of cancer patients are most likely to respond to different types of regional hypothermia, the ideal duration of cooling needed, and further improve the ease of use of the cooling devices.
CONTEXT: Conventional chemotherapy leads to multiple adverse mucocutaneous complications such as oral mucositis, alopecia, ocular toxicity, and onycholysis. Limited pharmacologic interventions are available for preventing these clinical problems. OBJECTIVES: This study aimed to critically review the role of cryotherapy (regional hypothermia) for alleviating these adverse symptoms. METHODS: A narrative review was performed, with an emphasis on randomized controlled trials. A comprehensive search using PubMed, Ovid, Embase, and MEDLINE(®) was completed. References of all cited articles also were reviewed. Data from the review were composed of articles published between 1970 and May 2013. RESULTS: Available evidence suggests that regional hypothermia decreases the burden of chemotherapy-related oral mucositis, alopecia, ocular toxicity, and onycholysis. The major limitations of studies include the absence of blinded control groups and variable clinical end points. CONCLUSION: Regional hypothermia decreases the burden of these four chemotherapy-induced complications and is well tolerated. More research is needed to determine what subgroups of cancerpatients are most likely to respond to different types of regional hypothermia, the ideal duration of cooling needed, and further improve the ease of use of the cooling devices.
Authors: Deborah B McGuire; Maria Elvira P Correa; Judith Johnson; Patricia Wienandts Journal: Support Care Cancer Date: 2006-04-25 Impact factor: 3.603
Authors: Francis-Paul E M Janssen; Carlijn V C Bouten; Gerard M J van Leeuwen; Anton A van Steenhoven Journal: In Vitro Cell Dev Biol Anim Date: 2008-01-11 Impact factor: 2.416
Authors: A Dueñas-Gonzalez; P Sobrevilla-Calvo; M Frias-Mendivil; D Gallardo-Rincon; F Lara-Medina; L Aguilar-Ponce; E Miranda-Lopez; J Zinser-Sierra; E Reynoso-Gomez Journal: Bone Marrow Transplant Date: 1996-05 Impact factor: 5.483
Authors: Viswanath Reddy Belum; Giselle de Barros Silva; Mariana Tosello Laloni; Kathryn Ciccolini; Shari B Goldfarb; Larry Norton; Nancy T Sklarin; Mario E Lacouture Journal: Breast Cancer Res Treat Date: 2016-05-05 Impact factor: 4.872
Authors: Ting Bao; Andrew D Seidman; Lauren Piulson; Emily Vertosick; Xi Chen; Andrew J Vickers; Victoria S Blinder; Wanqing I Zhi; Qing Li; Linda T Vahdat; Maura N Dickler; Mark E Robson; Jun J Mao Journal: Eur J Cancer Date: 2018-07-13 Impact factor: 9.162
Authors: Kathryn J Ruddy; Jennifer Le-Rademacher; Mario E Lacouture; Mary Wilkinson; Adedayo A Onitilo; Amy C Vander Woude; Maria T Grosse-Perdekamp; Travis Dockter; Angelina D Tan; Andreas Beutler; Charles L Loprinzi Journal: Breast Date: 2019-09-19 Impact factor: 4.380
Authors: Ángel López-González; Marta García-Quintanilla; Carmen María Guerrero-Agenjo; Jaime López Tendero; Isabel María Guisado-Requena; Joseba Rabanales-Sotos Journal: Int J Environ Res Public Health Date: 2021-01-23 Impact factor: 3.390
Authors: Natalia Mitin; Kirsten A Nyrop; Susan L Strum; Anne Knecht; Lisa A Carey; Katherine E Reeder-Hayes; E Claire Dees; Trevor A Jolly; Gretchen G Kimmick; Meghan S Karuturi; Raquel E Reinbolt; JoEllen C Speca; Erin A O'Hare; Hyman B Muss Journal: NPJ Breast Cancer Date: 2022-09-08